Markus Warmuth

Companies

• Monte Rosa TherapeuticsChief executive officer Mar 2, 2022 to now¹
• Monte Rosa TherapeuticsPresident Mar 2, 2022 to now¹
• Monte Rosa TherapeuticsBoard member Jun 23, 2021 to now²
• Monte Rosa TherapeuticsOfficer Jun 23, 2021 to Jun 25, 2021²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• MRMonte Rosa Therapeutics GLUE585,038 shares³$6.2M at $10.63Jul 16, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 16, 2026Sold 9,500 shares at $23.18 of Monte Rosa Therapeutics³
• Jun 1, 2026Sold 468 shares at $19.73 of Monte Rosa Therapeutics⁴
• Jun 1, 2026Sold 4,998 shares at $19.41 of Monte Rosa Therapeutics⁴
• May 1, 2026Sold 5,467 shares at $18.92 of Monte Rosa Therapeutics⁵
• Apr 14, 2026Sold 8,000 shares at $17.64 of Monte Rosa Therapeutics⁶
• Mar 2, 2026Sold 5,466 shares at $17.92 of Monte Rosa Therapeutics⁷
• Jan 7, 2026Sold 309 shares at $24.57 of Monte Rosa Therapeutics⁸
• Jan 7, 2026Sold 1,450 shares at $23.88 of Monte Rosa Therapeutics⁸
• Jan 7, 2026Sold 3,707 shares at $23.24 of Monte Rosa Therapeutics⁸
• Jan 5, 2026Sold 10,135 shares at $15.17 of Monte Rosa Therapeutics⁹
• Jan 2, 2026Granted 90,000 shares of Monte Rosa Therapeutics⁹
• Jan 2, 2025Granted 128,000 shares of Monte Rosa Therapeutics¹⁰